Washington, D.C.—The Food and Drug Administration (FDA) presented its Fiscal Year 2025 Budget Request, in support of the nationwide public health protection programs administered by FDA., and shared an FY 2025 FDA Budget Summary Fact Sheet. Regarding supplements, FDA said the budget "would provide FDA with additional authorities to increase oversight of dietary supplements to better protect consumers."

Following FDA's budget request, the Natural Products Association (NPA) issued statement regarding mandatory product listing:

“Year after year, the FDA’s budget proposal includes mandatory product listing. Congress has routinely shut down this proposal, another example of the FDA being distracted from doing the basics,” said Daniel Fabricant, Ph.D., President and CEO of NPA. “While the FDA continues to receive more funding, the previous price tag for mandatory product listing was $34 million and does not include the millions spent for the NIH Dietary Supplement Label Database.” 

As WholeFoods Magazine has reported, in 2022 House and Senate leaders  prevented mandatory product listing from being included in the FDA User Fee Reauthorization, with some influential members of Congress expressing concerns. “Congress has spoken on this issue," Dr. Fabricant said, "and giving FDA an administrative excuse to reject ingredients from being marketed as dietary supplements, regardless of the science or history, is a non-starter.” 

The topic of a mandatory listing has been met with a variety of viewpoints from the industry. Read up on the divide.

Related: FDA Issues Final Guidance on New Dietary Ingredient Notification Procedures and Timeframes

NPA Announces Annual Fly-in Day